Cyclomorusin exhibits significant antimicrobial activity, particularly against Gram-positive bacteria, making it a candidate for development in antibacterial agents. It also shows anti-inflammatory properties by inhibiting key inflammatory mediators such as nitric oxide and prostaglandins in cellular models. Additionally, cyclomorusin has demonstrated moderate cytotoxic effects against certain cancer cell lines, suggesting potential in anticancer research. Its ability to interact with cellular enzymes involved in oxidative stress further supports its role in neuroprotective and antioxidant applications. Studies indicate it may enhance insulin sensitivity, pointing to possible use in managing metabolic disorders like type 2 diabetes.